Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BioLase Technology, Inc. (BLTI) -- Ignore unavailable to you. Want to Upgrade?

To: JanyBlueEyes who wrote (183)	10/23/1997 1:51:00 PM
From: Karl Drobnic	Read Replies (1) \| Respond to of 706

I just reviewed the 10-Q BLTI filed in August. It states that BLTI had in hand a $500,000 order from Germany for shipment in 3Q, and that margins would improve (no discounts this time). This is for Millenium systems. If we add in a few DermaLase systems, and some cash from other products, revenues could easily be up 30% over the $433,000 booked in 2Q. The 10-Q also states that BLTI will invest in production equipment (capital spending), and to expect these expenses by 4Q. This suggests that capacity is being increased, and that suggests that revenues should increase again in 4Q, since BLTI would be able to build more units. 3Q should be reported in the next 3 weeks or so; we'll see how well the last 10-Q has guided us.